<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7730/10149262/e429605d4f17/gr3.jpg"/> </div> <div class="text-side"> <h1>Use of platinum-based chemotherapy and pembrolizumab to treat squamous cell carcinoma arising in a mature teratoma of the ovary in a pre-menopausal woman with negative response: A case report.</h1> <p>Malignant squamous cell carcinoma arising in a background of preexisting teratoma with squamous lined cyst and hair. (A) The photomicrograph shows a portion of the mass with benign squamous cyst lining (arrow). (B) Few hair shafts (arrows) are seen in the cyst contents (10x objective). (C) Invasive squamous cell carcinoma showing infiltrative nests of malignant cells into the stroma (40x objective). (D) P63 immunohistochemical stain showing positive nuclear staining which confirms squamous cell origin of the tumor (40x objective). (E) PD-L1 immunostain shows positive staining of the tumor cells (40x objective).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37131341/" target="_blank">37131341</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>